37.6 mg/mL · ≥ 37.6 mg/mL in DMSO, ≥ 47.8 mg/mL in EtOH with ultrasonic
form
Powder
pka
8.875 · 8.875±0.10(predicted)
color
Off-white to yellow
FDA UNII
99 Y1V29WVE · 99Y1V29WVE
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Safety data
Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338
Chemistry & industry
Applications
Uses6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3S)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine can be used as a protein kinase inhibitor useful in the treatment of protein kinase-mediated diseases.